High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates

被引:3
作者
Karakaya, Serdar [1 ]
Karadag, Ibrahim [2 ]
Yilmaz, Mehmet Emin [3 ]
Oksuzoglu, Omur Berna Cakmak [4 ]
机构
[1] Hlth Sci Univ, Med Oncol, Ataturk Chest Dis & Chest Surg Training & Res Hos, Ankara, Turkey
[2] Corum Hittite Univ Erol Olcok Training & Res Hosp, Dept Med Oncol, Corum, Turkey
[3] Hlth Sci Univ, Dept Internal Med, Ankara Dr Abdurrahman Yurtaslan Oncol Training &, Ankara, Turkey
[4] Hlth Sci Univ, Dept Med Oncol, Ankara Dr Abdurrahman Yurtaslan Oncol Training &, Ankara, Turkey
关键词
neoadjuvant chemoradiotherapy; rectum cancer; platelet-lymphocyte ratio; pathological response; neutrophil-lymphocyte ratio; TOTAL MESORECTAL EXCISION; RECTAL-CANCER; NEOADJUVANT CHEMORADIATION; PREOPERATIVE CHEMORADIOTHERAPY; POOR SURVIVAL; OPEN-LABEL; CHEMOTHERAPY; INFLAMMATION; THERAPY;
D O I
10.7759/cureus.22972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the effect of hemogram parameters on predicting pathological complete response (pCR) in locally advanced rectal cancer. Methodology: A total of 227 patients with rectal cancer treated with neoadjuvant concurrent chemoradiotherapy (CRT) were retrospectively analyzed. All patients were divided into two subgroups as high or low hemogram parameters according to the cut-off value obtained using the receiver operating characteristic (ROC) curve. Results: In patients with low neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) levels, pCR rate was statistically significantly higher than the group with high NLR and PLR levels (for NLR: 39.77% vs. 5.34%; p<0.001, for PLR: 32.38% vs 7.01%; p<0.001 respectively). In addition, the pCR rate was significantly better in patients with high lymphocyte levels compared to the group with low lymphocyte levels (33.33% vs. 7.5%; p<0.001, respectively). According to the multivariate logistic regression analysis result, NLR and PLR levels were considered as independent predictors to predict pathological complete response [p<0.001, HR: 0.128 (95% CI=0.051 - 0.322) for NLR; p=0.017, HR: 0.332 (95% CI=0.134 - 0.821) for PLR, respectively]. Conclusion: Our study showed that high NLR, PLR, and low lymphocyte levels were correlated with worse pCR rates. In addition to that, NLR and PLR emerged as independent predictive markers.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
    Allegra, Carmen J.
    Yothers, Greg
    O'Connell, Michael J.
    Beart, Robert W.
    Wozniak, Timothy F.
    Pitot, Henry C.
    Shields, Anthony F.
    Landry, Jerome C.
    Ryan, David P.
    Arora, Amit
    Evans, Lisa S.
    Bahary, Nathan
    Soori, Gamini
    Eakle, Janice F.
    Robertson, John M.
    Moore, Dennis F., Jr.
    Mullane, Michael R.
    Marchello, Benjamin T.
    Ward, Patrick J.
    Sharif, Saima
    Roh, Mark S.
    Wolmark, Norman
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (11):
  • [2] Andras D, 2020, J BUON, V25, P1436
  • [3] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 29 - 42
  • [4] Neutrophil-to-Lymphocyte Ratio in Rectal CancerNovel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun, Lore Helene
    Baumann, David
    Zwirner, Kerstin
    Eipper, Ewald
    Hauth, Franziska
    Peter, Andreas
    Zips, Daniel
    Gani, Cihan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [5] A predictive genetic signature for response to fluoropyrimidine-based neoadjuvant chemoradiation in clinical Stage II and III rectal cancer
    Chan, Jason
    Kinsella, Michael T.
    Willis, Joseph E.
    Hu, Huankai
    Reynolds, Harry, Jr.
    Delaney, Conor
    McCulla, Andrea
    Deharo, Steve
    Ahdesmaki, Miika
    Allen, Wendy Louise
    Johnston, Patrick G.
    Kinsella, Timothy J.
    [J]. FRONTIERS IN ONCOLOGY, 2013, 3
  • [6] Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
    Conroy, Thierry
    Bosset, Jean-Francois
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Francois, Eric
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    Morand, Clotilde
    de la Fouchardiere, Christelle
    Lamfichekh, Najib
    Juzyna, Beata
    Jouffroy-Zeller, Claire
    Rullier, Eric
    Marchal, Frederic
    Gourgou, Sophie
    Castan, Florence
    Borg, Christophe
    [J]. LANCET ONCOLOGY, 2021, 22 (05) : 702 - 715
  • [7] Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
    Dayde, Delphine
    Tanaka, Ichidai
    Jain, Rekha
    Tai, Mei Chee
    Taguchi, Ayumu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [8] Cancer-related inflammation and treatment effectiveness
    Diakos, Connie I.
    Charles, Kellie A.
    McMillan, Donald C.
    Clarke, Stephen J.
    [J]. LANCET ONCOLOGY, 2014, 15 (11) : E493 - E503
  • [9] Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
    Dudani, Shaan
    Marginean, Horia
    Tang, Patricia A.
    Monzon, Jose G.
    Raissouni, Soundouss
    Asmis, Timothy R.
    Goodwin, Rachel A.
    Gotfrit, Joanna
    Cheung, Winson Y.
    Vickers, Michael M.
    [J]. BMC CANCER, 2019, 19 (1)
  • [10] Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Eraslan, Emrah
    Adas, Yasemin Guzle
    Yildiz, Fatih
    Gulesen, Aysegul Ilhan
    Karacin, Cengiz
    Arslan, Ulku Yalcintas
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (04): : 399 - 404